CRISTIANO, GIANLUCA
 Distribuzione geografica
Continente #
NA - Nord America 371
EU - Europa 303
AS - Asia 39
AF - Africa 36
OC - Oceania 2
SA - Sud America 2
Totale 753
Nazione #
US - Stati Uniti d'America 371
IT - Italia 140
SE - Svezia 53
DE - Germania 31
IE - Irlanda 22
IN - India 21
TG - Togo 17
GB - Regno Unito 16
BG - Bulgaria 11
JO - Giordania 11
CI - Costa d'Avorio 9
NG - Nigeria 9
NL - Olanda 6
FI - Finlandia 5
ES - Italia 3
IR - Iran 3
MK - Macedonia 3
AT - Austria 2
AU - Australia 2
CH - Svizzera 2
CL - Cile 2
CN - Cina 2
HR - Croazia 2
RS - Serbia 2
CZ - Repubblica Ceca 1
FR - Francia 1
HU - Ungheria 1
KW - Kuwait 1
LI - Liechtenstein 1
PL - Polonia 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 753
Città #
Chandler 66
Bologna 40
Ann Arbor 35
Ashburn 23
Dublin 22
New York 18
Fairfield 17
Lomé 17
Milan 14
Princeton 14
Amman 11
Florence 11
Redmond 11
Sofia 11
Southend 10
Abeokuta 9
Abidjan 9
Bremen 7
Turin 6
Wilmington 6
Helsinki 5
Irvine 5
Amsterdam 4
Osimo 4
Reggio Emilia 4
York 4
Berlin 3
Castel Madama 3
Castellammare del Golfo 3
Dehradun 3
Des Moines 3
Frankfurt am Main 3
Kolkata 3
Madrid 3
Malvern 3
Rome 3
San Diego 3
Boydton 2
Busseto 2
Cambridge 2
Castenaso 2
Cervia 2
El Cerrito 2
Los Angeles 2
Marburg 2
Miradolo Terme 2
Modena 2
Ravenna 2
Romans d'Isonzo 2
San Francisco 2
Santiago 2
Skopje 2
Svilajnac 2
Vienna 2
Woodbridge 2
Acton 1
Andover 1
Beijing 1
Bern 1
Bitola 1
Boardman 1
Budapest 1
Budrio 1
Canberra 1
Canzo 1
Chicago 1
Clearwater 1
Dallas 1
Forlì 1
Henderson 1
Hyderabad 1
Kilburn 1
Kuwait City 1
Leawood 1
Lissone 1
London 1
Lucerne 1
Mannheim 1
Medford 1
Meppel 1
Missaglia 1
Naples 1
New Delhi 1
Pieve di Cento 1
Pomigliano d'Arco 1
Porcia 1
Povegliano Veronese 1
Prague 1
Seattle 1
Udine 1
Warsaw 1
Washington 1
Zanjan 1
Totale 490
Nome #
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 129
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia 112
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 98
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 91
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant 61
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients 51
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 45
Release of IFNg by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells 42
Clinical Efficacy of Ponatinib in Philadelphia-Positive T-Cell Acute Lymphoblastic Leukemia with Extramedullary Involvement 38
Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study 37
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents 34
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment 31
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure 17
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study 7
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia 6
Acute myeloid leukemia mutations: Therapeutic implications 1
Totale 800
Categoria #
all - tutte 2.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.997


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 3 2 1 0 5
2021/2022213 1 0 6 10 15 8 9 32 16 30 57 29
2022/2023386 37 43 10 35 54 31 10 38 68 8 32 20
2023/2024190 16 19 9 28 15 34 7 18 11 16 17 0
Totale 800